Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02713373
Title Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Roswell Park Cancer Institute
Indications

colorectal cancer

Therapies

Cetuximab + Pembrolizumab

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Roswell Park Cancer Institute Buffalo New York 14263 United States Details
University Hospitals Seidman Cancer Center Cleveland Ohio 44106 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field